Results 321 to 330 of about 4,227,388 (391)
Some of the next articles are maybe not open access.
Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance.
Rapid Communications in Mass Spectrometry, 2015 G. Frison, Sara Odoardi, Samuela Frasson, R. Sciarrone, G. Ortar, F. Romolo, S. Strano Rossi +6 moresemanticscholar +1 more sourceA case of fatal intoxication due to the new designer drug 25B-NBOMe
Forensic Toxicology, 2015 Ken-ichi Yoshida, Kanju Saka, Kaori Shintani-Ishida, Hideyuki Maeda, M. Nakajima, S. Hara, Masahide Ueno, Katsunori Sasaki, H. Iwase, T. Sakamoto +9 moresemanticscholar +1 more sourceStructure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues
Forensic Toxicology, 2015 S. Banister, J. Stuart, Trent Conroy, Mitchell Longworth, Madhura Manohar, C. Beinat, Shane M. Wilkinson, R. Kevin, D. Hibbs, M. Glass, M. Connor, I. McGregor, M. Kassiou +12 moresemanticscholar +1 more sourceMetabolism of the designer drug α-pyrrolidinobutiophenone (α-PBP) in humans: identification and quantification of the phase I metabolites in urine.
Forensic Science International, 2015 S. Matsuta, N. Shima, H. Kamata, Hidenao Kakehashi, Shihoko Nakano, K. Sasaki, Tooru Kamata, H. Nishioka, A. Miki, M. Katagi, K. Zaitsu, Takako Sato, H. Tsuchihashi, Koichi Suzuki +13 moresemanticscholar +1 more source
